Neuropsychological Assessment Should Always be Considered in Myotonic Dystrophy Type 2.
Theodosiou T, Christidi F, Xirou S, Bede P, Karavasilis E, Papadopoulos C, Kourtesis P, Pantoleon V, Kararizou E, Papadimas G, Zalonis I.
Theodosiou T, et al. Among authors: kararizou e.
Cogn Behav Neurol. 2021 Mar 3;34(1):1-10. doi: 10.1097/WNN.0000000000000263.
Cogn Behav Neurol. 2021.
PMID: 33652465
Review.